Akribion Therapeutics develops RNA-guided, nuclease-based technology for programmable cell depletion to treat diseases like cancer and autoimmune disorders.

Akribion Therapeutics is a biotech company developing RNA-guided, nuclease-based technology for programmable cell depletion to treat HPV-induced Oropharyngeal Head & Neck Cancer and other diseases.

Aignostics is a Berlin-based AI company that transforms multi-modal pathology data into insights for biopharmaceutical clients.

Symphera develops an innovative device that automates tool-switching during laparoscopic surgeries to simplify workflows and improve patient outcomes.

Thryve is a B2B health data integration and analytics company that aggregates data from wearable devices to provide continuous health monitoring and early disease detection.

inContAlert is a German MedTech startup developing a sensor-based technology to measure bladder filling levels and provide optimal voiding timings for incontinence patients, particularly those with neurogenic bladder disorders.